FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Legacy Pharmaceutical Packaging Fluoxetine Capsules Recall

Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, B…

Legacy Pharmaceutical Packaging · Earth City, MO

Risk level
Class II
Reported by FDA
May 7, 2014
Recall ID
D-1279-2014
Check your lot numberHow we source this data

Summary

Legacy Pharmaceutical Packaging recalled Fluoxetine Capsules starting Feb 14, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1279-2014 on May 7, 2014. Reason: Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor. Status: Terminated.

Why it was recalled

Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.

Product description

Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.

Lot numbers, UPCs & expiration codes

Lot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1279-2014
Classification
Class II
Status
Terminated
Recall initiated
Feb 14, 2014
FDA report date
May 7, 2014
Quantity
667,068 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Legacy Pharmaceutical Packaging

Original FDA data

Every field from FDA enforcement report D-1279-2014, exactly as published.

Show all FDA fields
City
Earth City
State
MO
Status
Terminated
Country
United States
Event ID
67526
Address
13333 Lakefront Dr
Code information
Lot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15
Postal code
63045-1514
Report date
May 7, 2014
Product type
Drugs
Recall number
D-1279-2014
Classification
Class II
Recalling firm
Legacy Pharmaceutical Packaging
Product quantity
667,068 bottles
Termination date
Nov 27, 2017
Reason for recall
Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.
Distribution pattern
Nationwide
Recall initiation date
Feb 14, 2014
Initial firm notification
Telephone
Center classification date
Apr 28, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1279-2014, published May 7, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls